Genetic screening of Fabry patients with EcoTILLING and HRM technology

被引：17

作者：

Bono C. ^{[1
]}

Nuzzo D. ^{[1
]}

Albeggiani G. ^{[1
]}

Zizzo C. ^{[1
]}

Francofonte D. ^{[1
]}

Iemolo F. ^{[2
]}

Sanzaro E. ^{[2
]}

Duro G. ^{[1
]}

机构：

[1] National Research Council-Institute of Biomedicine and Molecular Immunology (CNR-IBIM), Palermo

[2] Department of Neurology, Guzzardi Hospital, Vittoria (Ragusa)

来源：

BMC Research Notes | / 4卷 / 1期

关键词：

Anderson-Fabry; EcoTILLING; haplotype; HRM; screening;

D O I：

10.1186/1756-0500-4-323

中图分类号：

学科分类号：

摘要：

Background: Anderson-Fabry disease (FD) is caused by a deficit of the -galactosidase A enzyme which leads to the accumulation of complex sphingolipids, especially globotriaosylceramide (Gb3), in all the cells of the body, causing the onset of a multi-systemic disease with poor prognosis in adulthood. In this article, we describe two alternative methods for screening the GLA gene which codes for the -galactosidase A enzyme in subjects with probable FD in order to test analysis strategies which include or rely on initial pre-screening. Findings. We analyzed 740 samples using EcoTILLING, comparing two mismatch-specific endonucleases, CEL I and ENDO-1, while conducting a parallel screening of the same samples using HRM (High Resolution Melting). Afterwards, all samples were subjected to direct sequencing. Overall, we identified 12 different genetic variations: -10C>T, -12G>A, -30G>A, IVS2-76-80del5, D165H, C172Y, IVS4+16A>G, IVS4 +68 A>G, c.718-719delAA, D313Y, IVS6-22C>T, G395A. This was consistent with the high genetic heterogeneity found in FD patients and carriers. All of the mutations were detected by HRM, whereas 17% of the mutations were not found by EcoTILLING. The results obtained by EcoTILLING comparing the CEL I and ENDO-1 endonucleases were perfectly overlapping. Conclusion: On the basis of its simplicity, flexibility, repeatability, and sensitivity, we believe that HRM analysis of the GLA gene is a reliable presequencing screening tool. This method can be applied to any genomic feature to identify known and unknown genetic alterations, and it is ideal for conducting screening and population studies. © 2011Nuzzo et al; licensee BioMed Central Ltd.

引用

共 39 条

[1] Hoffman B., Fabry disease: Recent avances in pathology, diagnosis, treatment and monitoring, Orphanet J Rare Dis, 4, (2009)
[2] Aerts J.M., Groener J.E., Kuiper S., Donker-Koopman W.E., Strijland A., Ottenhoff R., Van Roomen C., Mirzaian M., Wijburg F.A., Linthorst G.E., Vedder A.C., Rombach S.M., Cox-Brinkman J., Somerharju P., Boot R.G., Hollak C.E., Brady R.O., Poorthuis B.J., Elevated globotriaosylsphingosine is a hallmark of Fabry disease, Proceedings of the National Academy of Sciences of the United States of America, 105, 8, pp. 2812-2817, (2008)
[3] Shen J.-S., Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells, Mol Genet Metab, 95, 3, pp. 163-168, (2008)
[4] Linhart A., Elliott P.M., The heart in Anderson-Fabry disease and other lysosomal storage disorders, Heart, 93, 4, pp. 528-535, (2007)
[5] Schiffmann R., Fabry disease: Progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy, Nephrol Dial Transplant, 24, 7, pp. 2102-2111, (2009)
[6] Shows T.B., Brown J.A., Haley L.L., Assignment of α-galactosidase (αGAL) to the q22→qter region of the X chromosome in man, Cytogenetics and Cell Genetics, 22, 1, pp. 541-544, (1978)
[7] Eng C.M., Resnick-Silverman L.A., Niehaus D.J., Astrin K.H., Desnick R.J., Nature and frequency of mutations in the α-galactosidase A gene that cause Fabry disease, American Journal of Human Genetics, 53, 6, pp. 1186-1197, (1993)
[8] Filoni C., Functional studies of new GLA gene mutations leading to conformational fabry disease, Biochimica et Biophysica Acta, 1802, pp. 247-252, (2010)
[9] Lin H.Y., Novel human pathological mutations. Gene symbol: GLA. Disease: Fabry disease, Hum Genet, 127, 1, (2010)
[10] Eng C.M., Resnick-Silverman L.A., Niehaus D.J., Astrin K.H., Desnick R.J., Nature and frequency of mutations in the α-galactosidase A gene that cause Fabry disease, American Journal of Human Genetics, 53, 6, pp. 1186-1197, (1993)

← 1 2 3 4 →